Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.

● According to Refinitiv, the company's ESG score for its industry is poor.


Strengths

● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.

● The earnings growth currently anticipated by analysts for the coming years is particularly strong.

● Before interest, taxes, depreciation and amortization, the company's margins are particularly high.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● The company is in a robust financial situation considering its net cash and margin position.

● Its low valuation, with P/E ratio at 2.66 and 2.04 for the ongoing fiscal year and 2023 respectively, makes the stock pretty attractive with regard to earnings multiples.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● Over the past four months, analysts' average price target has been revised upwards significantly.


Weaknesses

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● Over the past twelve months, analysts' opinions have been revised negatively.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.